AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own ATI, you generally need to believe in its shift toward higher value aerospace and defense materials, supported by long-term OEM contracts and capacity investments. The new US$80,000,000 Chihuahua forging facility fits that story by expanding complex manufacturing, but it does not fundamentally change the key near term swing factors: execution on aerospace ramp ups and the ongoing drag from weaker industrial and medical demand, along with the risk of heavy capital spending pressuring free cash flow.
The most relevant prior announcement is ATI’s multi year titanium supply deal with Airbus, which anchors a large portion of its aerospace growth thesis. That agreement, combined with the Chihuahua plant’s focus on advanced forgings, reinforces ATI’s role in high performance materials for major airframe programs and could matter for how investors think about order visibility, capital intensity and the balance between growth investments and returns of cash via buybacks.
But alongside this growth, investors should also pay close attention to the rising capital intensity and what it could mean for ATI’s...
Read the full narrative on ATI (it's free!)
ATI's narrative projects $5.9 billion revenue and $874.1 million earnings by 2029.
Uncover how ATI's forecasts yield a $200.33 fair value, in line with its current price.
Some of the lowest ranked analysts were already cautious, assuming earnings of about US$838.3 million by 2029, and the Chihuahua expansion could either challenge their concern about capital intensity or reinforce it, depending on how you weigh long term growth against nearer term cash demands.
Explore 6 other fair value estimates on ATI - why the stock might be worth as much as 6% more than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Our top stock finds are flying under the radar-for now. Get in early:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com